|
|
 |
 |
 |
|
|
|||
|
||||
|
||||
Re: Breast cancerFrom: guy venezia (venezia.gaetano@mhsil.com)Mon Aug 16 16:07:41 1999
At Sat, 14 Aug 1999, BJ Ligon wrote: > >James Connerth MD wrote: > >> Is anyone actually discussing or prescribing tamoxifen >> to young women with Gail risk >1.7%??? > >yes thanks for asking the question again!!! i got very little response last month when i brought up th issue of nolvadex and use with progest. i am talking to women about this and am giving a lecture on breast cancer tonight to area women. it seems to point to a good recommendation. i do the gail model and talk to women. have not completely jumped on board but think it is of value. recent study in JAMA (june) is even more encouraging concerning evista. awaiting star trial, but will begin to offer itmore to my pts. hope we get some feedback on line here!!! gaetano
-- gaetano
|
|
Return to
|
Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Mon Nov 2 05:32:16 2009 |
The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.